ClinicalTrialsFinder

Advanced ER+/HER2- Breast Cancer Clinical Trials in Shanghai

1 recruitingShanghai, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients

Advanced ER+/HER2- Breast Cancer
Qilu Pharmaceutical Co., Ltd.300 enrolled1 locationNCT07235176